|Expense Ratio (net)||N/A|
|Last Cap Gain||N/A|
|Morningstar Risk Rating||N/A|
|Beta (3Y Monthly)||N/A|
|5y Average Return||N/A|
|Average for Category||N/A|
Apolo II Acquisition Corp. (the “Corporation”), a “capital pool company” pursuant to the policies of the TSX Venture Exchange (the “Exchange”), is pleased to announce that it has entered into a definitive business combination agreement (the “Definitive Agreement”) dated July 17, 2019 with Terrace Inc. (“Terrace”) and Terrance Acquisition Corp. (a wholly-owned subsidiary of the Corporation) (“Subco”) in furtherance of the Corporation’s previously announced proposed Qualifying Transaction (as such term is defined in Policy 2.4 – Capital Pool Companies of the Exchange’s Corporate Finance Manual (the “Manual”)) (the “Proposed Transaction”). Terrace was incorporated pursuant to the provisions of the Business Corporations Act (Ontario) (the “OBCA”) on August 28, 2018.
TORONTO, Sept. 19, 2018 /CNW/ - Lift & Co. Corp. ("Lift & Co." or the "Company") (TSXV:LIFT) announces the appointment of Stu Miller as Board Chair and Deborah Rosati as Vice Chair of the Board. "We are pleased to have such accomplished board members as Stu and Deborah to join Lift & Co.'s Board of Directors.
CORAL GABLES, FL / ACCESSWIRE / July 27, 2018 / The marijuana industry and marijuana stocks in general have been getting a lot more attention lately.Canada’s decision to legalize recreational marijuana on a national scale has jump-started the market once again.The summer however has typically been a time where pot stocks are more steady and not as aggressively volatile leading into the 3rd quarter. This year has seen some of the biggest cannabis IPO’s and this may be a trend that is far from over.Though some marijuana stocks may have consolidated, there are others that have blossomed just this week, to fresh weekly highs. Leafbuyer Technologies (LBUY) finds itself hitting early morning highs of $1.23.This is higher by nearly 11% from this week’s lows of $1.11.
WKN: A1C4WM) and MedReleaf Corp. ("MedReleaf") (TSX:LEAF.TO - News) today announced the closing of the previously announced arrangement agreement (the "Arrangement Agreement"). Under the terms of the Arrangement Agreement, holders of MedReleaf common shares received 3.575 common shares of Aurora for each MedReleaf common share held (the "Exchange Ratio"). Upon closing of the transaction, Aurora will submit applications with the Toronto Stock Exchange (the "TSX") and the Ontario Securities Commission (the "OSC") to delist MedReleaf's existing common shares and for MedReleaf to cease to be a reporting issuer, respectively.
MARKHAM, ON, July 24, 2018 /CNW/ - MedReleaf Corp. (TSX:LEAF.TO - News) ("MedReleaf" or the "Company") today announced that it has acquired MED Colombia SAS ("MED Colombia"), a company with licences in Colombia to cultivate cannabis and produce cannabis oil extracts, along with a library of cannabis genetics, for a total consideration of €2.75 million in cash. This acquisition provides MedReleaf with the ability to produce low-cost, high-quality raw materials to serve its global supply chain as well as the domestic Colombian medical cannabis market. "As the legalization of medical cannabis continues to expand, we must ensure that our ability to cultivate cost effectively extends beyond Canada to supply our global operations," said Neil Closner, CEO of MedReleaf.